TROBALT

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug TROBALT contains one active pharmaceutical ingredient (API):

1 Retigabine UNII 12G01I6BBU - EZOGABINE

In vitro studies indicate that retigabine acts primarily through opening neuronal potassium channels. This stabilises the resting membrane potential and controls the sub-threshold electrical excitability in neurons, thus preventing the initiation of epileptiform action potential bursts. The mechanism of action of retigabine on potassium channels has been well documented, however other mechanisms by which retigabine may assert an antiepileptic effect have yet to be fully elucidated. Read about Retigabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TROBALT Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AX21	Retigabine	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1524776, 1524787, 1524798, 1524800, 1524811, 1524822, 1524844, 1524855, 1524866, 1524877, 1524888, 1524899, 1524901, 1666212
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1059875, 1059876, 1059878, 1059879, 1059881, 1059882, 1059883, 1059884, 1059885, 1059886